Found: 29
Select item for more details and to access through your institution.
Safety, tolerability and immunogenicity of an active anti‐Aβ40 vaccine (ABvac40) in patients with amnestic mild cognitive impairment (A‐MCI) or very mild alzheimer's disease (VM‐AD): A randomized, double‐blind, placebo‐controlled, phase II trial: Human/Human trials: Anti‐amyloid
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045720
- By:
- Publication type:
- Article
AB1601 Phase 2 Study of ABvac40, an Anti‐Aβ40 Vaccine: Safety and Immunogenicity of a Cross‐Over Extension.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082952
- By:
- Publication type:
- Article
AB1601 topline results – Phase 2 study of ABvac40 in patients with amnestic mild cognitive impairment (a‐MCI) or very mild Alzheimer's Disease (Vm‐AD).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.065633
- By:
- Publication type:
- Article
The Aβ42/Aβ40 ratio in plasma is associated with amyloid‐PET status and rate of progression in individuals with subjective cognitive decline: The Fundació ACE Healthy Brain Initiative: Biomarkers (non‐neuroimaging) / plasma/serum/urine biomarkers
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045780
- By:
- Publication type:
- Article
O1‐07‐01: LONGITUDINAL EVALUATION OF THE NATURAL HISTORY OF Aβ IN PLASMA AND BRAIN.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P210, doi. 10.1016/j.jalz.2019.06.4553
- By:
- Publication type:
- Article
P4‐189: ABVAC40 TREATMENT IN DOGS INDUCES SPECIFIC ANTIBODY RESPONSE AND INCREMENT OF Aβ40 LEVELS IN PLASMA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1512, doi. 10.1016/j.jalz.2018.06.2594
- By:
- Publication type:
- Article
Safety, tolerability and immunogenicity of an active anti-Aβ<sub>40</sub> vaccine (ABvac40) in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase I trial.
- Published in:
- Alzheimer's Research & Therapy, 2018, v. 10, p. 1, doi. 10.1186/s13195-018-0340-8
- By:
- Publication type:
- Article
ANTI-AβX-40 ANTIBODIES EXERT NEUROPROTECTIVE EFFECT AGAINST Aβ-OLIGOMER TOXICITY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1439, doi. 10.1016/j.jalz.2017.06.2255
- By:
- Publication type:
- Article
AN ACTIVE ANTI-AB40 VACCINE (ABVAC40) PROVED TO BE SAFE AND IMMUNOGENIC IN THE PHASE I CLINICAL TRIAL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P199, doi. 10.1016/j.jalz.2016.06.348
- By:
- Publication type:
- Article
Total plasma Aβ42/40 ratio is an early biomarker of Alzheimer’s disease progression.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P871, doi. 10.1016/j.jalz.2015.08.067
- By:
- Publication type:
- Article
Cognitive composites and prodromal Alzheimer’s disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P707, doi. 10.1016/j.jalz.2015.06.1567
- By:
- Publication type:
- Article
Beta-amyloid-17 is a major beta-amyloid fragment isoform in cerebrospinal fluid and blood that shows diagnostic value
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Aβ blood levels and Alzheimer's disease.
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Early diagnosis and preventive treatment of Alzheimer's with isoform-specific Aβ antibodies
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Immunization of dogs with C-terminal sequences of beta-amyloid protein is safe and depletes the protein from the blood
- Published in:
- 2009
- By:
- Publication type:
- Abstract
The deposition of Aß40 in the brain is pathognomonic for Alzheimer-type dementia in Down syndrome
- Published in:
- 2009
- By:
- Publication type:
- Abstract
P4-157: Neurofibrillary tangles of Aβ40 in Alzheimer brains
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Neprilysin Is Poorly Expressed in the Prefrontal Cortex of Aged Dogs with Cognitive Dysfunction Syndrome.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Neprilysin Is Poorly Expressed in the Prefrontal Cortex of Aged Dogs with Cognitive Dysfunction Syndrome.
- Published in:
- International Journal of Alzheimer's Disease, 2014, p. 1, doi. 10.1155/2014/483281
- By:
- Publication type:
- Article
Reliable Measurements of the β-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Reliable Measurements of the β-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD.
- Published in:
- International Journal of Alzheimer's Disease, 2012, p. 1, doi. 10.1155/2012/604141
- By:
- Publication type:
- Article
Blood Amyloid Beta Levels in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Individuals: Replication of Diastolic Blood Pressure Correlations and Analysis of Critical Covariates.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0081334
- By:
- Publication type:
- Article
Blood Markers in Healthy-Aged Nonagenarians: A Combination of High Telomere Length and Low Amyloidβ Are Strongly Associated With Healthy Aging in the Oldest Old.
- Published in:
- Frontiers in Aging Neuroscience, 2018, p. N.PAG, doi. 10.3389/fnagi.2018.00380
- By:
- Publication type:
- Article
Proinflammatory cytokine levels in fibromyalgia patients are independent of body mass index.
- Published in:
- BMC Research Notes, 2010, v. 3, p. 156, doi. 10.1186/1756-0500-3-156
- By:
- Publication type:
- Article
The Clinical Significance of Plasmatic Amyloid Aβ-40 Peptide Levels in Alzheimer's Disease Patients Treated With Galantamine.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2008, v. 23, n. 3, p. 286, doi. 10.1177/1533317507313675
- By:
- Publication type:
- Article
βAPP Gene Expression is Increased in the Rat Brain After Motor Neuron Axotomy.
- Published in:
- European Journal of Neuroscience, 1993, v. 5, n. 7, p. 795, doi. 10.1111/j.1460-9568.1993.tb00931.x
- By:
- Publication type:
- Article
Clinical utility of an antibody‐free LC‐MS method to detect brain amyloid deposition in cognitively unimpaired individuals from the screening visit of the A4 Study.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2023, v. 15, n. 2, p. 1, doi. 10.1002/dad2.12451
- By:
- Publication type:
- Article
Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer's disease in individuals with subjective cognitive decline.
- Published in:
- Alzheimer's Research & Therapy, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13195-022-01143-z
- By:
- Publication type:
- Article
Gentamicin causes endocytosis of Na/Pi cotransporter protein (NaPi-2).
- Published in:
- Kidney International, 2001, v. 59, n. 3, p. 1024, doi. 10.1046/j.1523-1755.2001.0590031024.x
- By:
- Publication type:
- Article